コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ntribute to neuronal plasticity and disease, is lacking.
2 s and their association with clinical events is lacking.
3 Evidence for best management is lacking.
4 c peptides to which central immune tolerance is lacking.
5 f age across forests and canopy environments is lacking.
6 though current evidence for such a mechanism is lacking.
7 ut experimental evidence for this prediction is lacking.
8 tional characterization of this substitution is lacking.
9 the structure and function of the L protein is lacking.
10 ndards, and its potential as a research tool is lacking.
11 gy in schistosomiasis japonica endemic areas is lacking.
12 characterization of changes in the lipidome is lacking.
13 ral mosaicism using targeted sequencing data is lacking.
14 available, but software to analyze turnover is lacking.
15 ence for the involvement of feedback signals is lacking.
16 ut cccDNA formation, stability, and turnover is lacking.
17 could be a promising strategy, but evidence is lacking.
18 ated differences of their carotenoid profile is lacking.
19 on failure during environmental perturbation is lacking.
20 ion of ECM proteins such as fibronectin (FN) is lacking.
21 ut noninvasive assessment of PDE5 expression is lacking.
22 even information on its biological assembly is lacking.
23 standing of the DDR at a physiological level is lacking.
24 understanding of their functional diversity is lacking.
25 adsorbate frequencies scale across materials is lacking.
26 s of cephalosporin resistance in E. faecalis is lacking.
27 aries create surfaces with enhanced activity is lacking.
28 ework for understanding variation in surfing is lacking.
29 forest resources in Central Asian countries is lacking.
30 direct experimental evidence for these sites is lacking.
31 tion balance modifies D1 and D2 MSN activity is lacking.
32 transcriptional signature of the stem cells is lacking.
33 suturing technique in the emergency setting is lacking.
34 and progression of the disease in childhood is lacking.
35 r data, but robust evidence specific to DCIS is lacking.
36 ng for experience and research productivity, is lacking.
37 ar biology of ascovirus replication in vitro is lacking.
38 However, in vivo evidence for this proposal is lacking.
39 rOCs uptake and intracellular transformation is lacking.
40 ning strategies are implemented in the brain is lacking.
41 direct evidence for their action on biomass is lacking.
42 ormation on sex-specific recurrence patterns is lacking.
43 lular and in vivo evidence for this proposal is lacking.
44 iated with eczema development and prediction is lacking.
45 triatum-related neurophysiology and behavior is lacking.
46 omprehensive quantitative assessment of this is lacking.
47 cale estimate of hunting-induced defaunation is lacking.
48 renal failure; however, effective treatment is lacking.
49 but functional evidence for their corelease is lacking.
50 ibe after common general surgical procedures is lacking.
51 ndividuals to achieve these functional goals is lacking.
52 alk with the redox system under shear stress is lacking.
53 e for how DnaB functions at the atomic level is lacking.
54 and facilitates comparative outcome analyses is lacking.
55 ental scale and across different soil depths is lacking.
56 date, comprehensive genomic analysis of SBA is lacking.
57 ) surfaces, clear guidance for ligand design is lacking.
58 effects on different life-history strategies is lacking.
59 the nature of the dose-response relationship is lacking.
60 se/anti-sense transcript mapping information is lacking.
61 of a quasicrystal from a parent liquid phase is lacking.
62 oholic fatty liver disease (NAFLD) over time is lacking.
63 ng its impact on HIV-infected pregnant women is lacking.
64 is phenomenon across various physical scales is lacking.
65 ve method to measure Ub/UBL activation by E1 is lacking.
66 high-quality evidence for its effectiveness is lacking.
67 ation about the interaction of TPX2 with MTs is lacking.
68 leton spatially defines cell-plate formation is lacking.
69 as a black box, and a truly systematic study is lacking.
70 regulatory modules across the transcriptome is lacking.
71 d the transport of atmospheric air pollution is lacking.
72 induced by PD-1 blockade in cancer patients is lacking.
73 of the factors that regulate these networks is lacking.
74 iurnal, although molecular evidence for this is lacking.
75 iled synthesis of OIT's mechanisms of action is lacking.
76 estradiol contributes to this vulnerability is lacking.
77 but a complete understanding of its function is lacking.
78 relates elicited by early-life social stress is lacking.
79 (anti-TNF) in treating cutaneous sarcoidosis is lacking.
80 effective model of inflorescence patterning is lacking.
81 ) is recommended, although clinical evidence is lacking.
82 the STN causally implements stops or pauses is lacking.
83 edge regarding its influence on the proteome is lacking.
84 large series involving single-organ systems are lacking.
85 olence within countries and around the world are lacking.
86 have remained elusive, and robust biomarkers are lacking.
87 Comparable data in adults are lacking.
88 eekends and evidence for its relative safety are lacking.
89 the identity and binding sites of these RNAs are lacking.
90 nt of infections in critically ill patients, are lacking.
91 astatic renal cell carcinoma (mRCC) patients are lacking.
92 Data on the burden of GBS in Asian countries are lacking.
93 to 6 months, evidence-based recommendations are lacking.
94 presence and degree of small airway disease are lacking.
95 rity of organ systems when dietary nutrients are lacking.
96 s of bacteriuria management among inpatients are lacking.
97 iations in drug response in asthma treatment are lacking.
98 ES) on measures of LV structure and function are lacking.
99 ial infarction (MI) induced cardiac fibrosis are lacking.
100 effects of BPF and BPS on obesity in humans are lacking.
101 ural networks in primary progressive aphasia are lacking.
102 these patterns and processes across studies are lacking.
103 complications for which epidemiological data are lacking.
104 ts for eyes with early or equivocal findings are lacking.
105 redictive information from protocol biopsies are lacking.
106 predicting the therapeutic response to Ara-C are lacking.
107 l nodes are obtained, but long-term outcomes are lacking.
108 omprehensive attempts aiming at a resolution are lacking.
109 dysplasia, but appropriately designed trials are lacking.
110 of green plants, although direct comparisons are lacking.
111 e, that predict asthma inception in children are lacking.
112 udies that mimic a realistic in vivo setting are lacking.
113 atients receiving vancomycin + cefepime (VC) are lacking.
114 n dynamics in mixed communities in the anode are lacking.
115 advanced breast cancer with liver metastasis are lacking.
116 up studies evaluating bowel function and QoL are lacking.
117 advSM but biomarkers predictive of response are lacking.
118 imental tests of this cross-ecosystem theory are lacking.
119 central lumen network as an endocrine niche are lacking.
120 reatments aiming at dystrophin re-expression are lacking.
121 tiveness of TAS2R agonists in disease models are lacking.
122 comparisons between models and "omics" data are lacking.
123 rceptual learning, formal tests of causality are lacking.
124 itor the long treatment of tuberculosis (TB) are lacking.
125 re diseases, the definitive diagnostic means are lacking.
126 large communities of interacting competitors are lacking.
127 es for clinical trials on cerebellar ataxias are lacking.
128 f ACP and recommendations concerning its use are lacking.
129 hensive palmitoylation site characterization are lacking.
130 te estimates of MDR-TB burden among children are lacking.
131 xia affects lipid metabolism in chondrocytes are lacking.
132 ain metastases at diagnosis of breast cancer are lacking.
133 ncer (NSCLC), but long-term prospective data are lacking.
134 in severity of disease and clinical outcomes are lacking.
135 rome, studies characterizing natural disease are lacking.
136 ted to optimize metal active-site properties are lacking.
137 rmed, but large randomized controlled trials are lacking.
138 re poorly understood and effective therapies are lacking.
139 atients who have undergone Fontan procedures are lacking.
140 studies from which to draw global inferences are lacking.
141 he events that drive this synaptic pathology are lacking.
142 art failure with preserved ejection fraction are lacking.
143 to engage patients and care partners in ICUs are lacking.
144 direct experimental evidence for such models are lacking.
145 al selection within established human tumors are lacking.
146 however, mechanisms regulating this coupling are lacking.
147 plant patients, but data in de novo patients are lacking.
148 is or encephalitis in the United States (US) are lacking.
149 between infection and disease susceptibility are lacking.
150 ctly comparing different immune repertoires, are lacking.
151 ver surgery alone, although prospective data are lacking.
152 Tools to assess severity and predict outcome are lacking.
153 gional scales, large continental-scale tests are lacking.
154 ive, high-quality evaluations of these tests are lacking.
155 Biomarkers of macronutrient intake are lacking.
156 is and management of carcinoid heart disease are lacking.
157 to be rising, but updated epidemiologic data are lacking.
158 cular system, data on their clinical effects are lacking.
159 ta across different clinical characteristics are lacking.
160 sing community structure in terms of biomass are lacking.
161 ion of GABAA receptors in the human amygdala are lacking.
162 g expansion speed but controlled experiments are lacking.
163 els aimed at characterizing these mechanisms are lacking.
164 nalyses examining their simultaneous effects are lacking.
165 tic kidney disease (DKD) progression to ESRD are lacking.
166 Preventive interventions post trauma are lacking.
167 dary prevention treatment in MINOCA patients are lacking.
168 ata for low levels of prenatal lead exposure are lacking.
169 ever, results on long-term clinical outcomes are lacking.
170 ly since animal models representing human AD are lacking.
171 big-data approaches assessing sleep dynamics are lacking.
172 parisons of these novel treatments, however, are lacking.
173 fluorescence with small organic fluorophores are lacking.
174 mimic the natural stages of CRC progression are lacking.
175 inical trials comparing these two treatments are lacking.
176 period, but data on recent incidence trends are lacking.
177 l studies focused on these terrestrial frogs are lacking.
178 y remain unresolved, and effective therapies are lacking.
179 h impacts of complex environmental exposures are lacking.
180 n maternal GBS disease in developing regions are lacking.
181 for identifying these ICU patient subgroups are lacking.
182 way on response to vitamin D supplementation are lacking.
183 g the cellular origin of gray matter changes are lacking.
184 ne mutations in these 4 newly included genes are lacking.
185 who underwent EA/TEF repair because infants are lacking.
186 t mechanistic insights into this association are lacking.
187 ty during extended wake, but direct evidence was lacking.
188 Up to now evidence to test this hypothesis was lacking.
189 odel system to measure R258C-induced effects was lacking.
190 phage inflammatory proteins-1beta) when CD73 was lacking.
191 ant compared with other Ebola virus variants was lacking.
192 vidual reactions of the contact pathway have been lacking.
193 r structure and dynamics in living cells has been lacking.
194 r, a rationale for its apical expression has been lacking.
195 n, and methodologies for answering this have been lacking.
196 anical current activation in these cells has been lacking.
197 chanical stability and cellular response has been lacking.
198 rimental evidence supporting this notion has been lacking.
199 amics of body mass and population growth has been lacking.
200 c approach for identifying such proteins has been lacking.
201 ever, direct evidence for this mechanism has been lacking.
202 T) enzymes that catalyze these reactions has been lacking.
203 hods of population-based implementation have been lacking.
204 ildren after HUS due to E. coli O104:H4 have been lacking.
205 nosuppressants in transplant recipients have been lacking.
206 ctions, but study of inorganic materials has been lacking.
207 e structures, but different composition, has been lacking.
208 rgy and off-diagonal tunnelling disorder has been lacking.
209 y of chiral inorganic nanocrystals (NCs) has been lacking.
210 ion and metastasis, but in vivo evidence has been lacking.
211 antioxidants and TB incidence in humans has been lacking.
212 s and spectral properties to BG function has been lacking.
213 ic biochemical roles for the two domains has been lacking.
214 turbance, although quantifiable effects have been lacking.
215 pre- from the post-Aire MHCII(lo) stage has been lacking.
216 OM chemical composition at the nanoscale has been lacking.
218 nderlying assumption of restricted migration are lacking and it is also unknown whether the originall
219 However, relevant thermodynamic parameters are lacking, and equilibrium thermodynamic methods are o
220 surveillance mammography in this population are lacking, and most of the evidence is derived from ob
222 rug treatments for many psychiatric diseases are lacking, and the emerging tools and approaches outli
223 a major hurdle because type-specific markers are lacking, and the frequently used neuropeptide/CaBP s
225 bservation of the structural transitions has been lacking, and the underlying processes of framework
227 pancy of a polymerizing transcription factor is lacking, and such a description would have broader ap
228 e pathophysiology, diagnosis, and management are lacking; and clinical outcomes are poorly establishe
229 very 5 years, but evidence of mortality risk is lacking at air pollution levels below the current dai
231 multidrug-resistant (MDR) tuberculosis (TB) are lacking because published data consist of small obse
232 he peptides presented by these molecules has been lacking behind the more abundant HLA-A and HLA-B ge
235 an unbiased, reproducible, and efficient way are lacking, considerably limiting the advancement of re
236 work for predicting accumulation changes has been lacking, despite the importance of accumulations fo
237 obiomes in larval Lepidoptera (caterpillars) is lacking, despite the fact that these insects are enor
238 stimates of the total forest carbon (C) pool are lacking due to insufficient information on dead orga
239 channel pore, but experimental verification is lacking due to the sensitivity of this structure to c
241 omoting bioactive compounds and antioxidants are lacking, especially in Himalayan wild edible fruits.
242 gy and biochemistry of oleaginous microalgae is lacking, especially under nitrogen deprivation condit
243 39 of 386 T-ALL cases) and B-other ALL, that is, lacking established chromosomal abnormalities (5.6%;
244 atory syncytial virus (RSV) treatment trials are lacking for hematopoietic cell transplant (HCT) reci
245 y of high-throughput data types, but methods are lacking for integrative analysis of multiomics exper
250 ntitative understandings of the subject have been lacking for decades due to the fact that vacancies
251 al elaborate targeting schemes, yet evidence is lacking for genetic coupling that results in the co-r
252 with a few exceptions, such causal relation is lacking for humans and most publications merely repor
255 eferentially in inner hair cells (IHCs), and was lacking from the postsynaptic spiral ganglion neuron
256 e conceptually attractive, clinical efficacy is lacking given several key challenges stemming from th
258 function and health-related quality of life are lacking in long-term follow-up of patients who remai
259 owever, reliable data to estimate CVD burden are lacking in many regions of the world, which hampers
267 l agents of WPND are known, current research is lacking in both sampling distribution and the specifi
271 aracterization of intracellular ion channels is lacking, mainly because standard methods to analyze p
272 e shifts, especially when more detailed data are lacking on dispersal dynamics, demographic processes
280 tions of CS-based nanocarriers, but a review is lacking on the role and prospects of different factor
282 hip of arthritis with mental health outcomes are lacking, particularly among low- and middle-income c
283 r, to date, prospective head-to-head studies are lacking regarding the diagnostic accuracy of these i
285 atment increases fracture risk, and evidence is lacking regarding the efficacy of alendronate to prot
286 perchloroethylene (PERC), experimental data are lacking, resulting in default assumptions being used
287 m cell cycle progression when MCPH1 function is lacking, resulting in cells that prematurely condense
288 ase characteristics when traditional sources are lacking, such as in basal and squamous cell carcinom
289 articularly important when genetic variation is lacking, such as in small, bottlenecked, or asexual p
290 however, are limited, because robust methods are lacking that enable automatic segmentation and quant
293 inst cancer stem cells in endometrial cancer is lacking, the ability of anti-EMP2 IgG1 therapy to red
294 alidation of the mismatch selection paradigm is lacking, the use of this paradigm as a surrogate mark
296 atic species, particularly in North America, is lacking, thereby hindering conservation and managemen
300 of obesity, but intergenerational human data are lacking.We prospectively investigated refined-grain
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。